Accretion Pharmaceuticals
ACCPL •NSE

Accretion Pharmaceuticals

₹202.50-9.50 (4.48%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
201.40
Today’s high
219.85
52 week low
54.60
52 week high
220.00
Open price
219.85
Previous close
212.00
Live volume
23,400
Lower circuit
192.40
Upper circuit
212.60

Fundamentals

Market Cap
₹236Cr
ROE
20.85%
P/E Ratio(TTM)
24.37
EPS(TTM)
8.70
P/B Ratio
4.31
Dividend Yield
0.00%
Industry P/E
50.89
Book Value
49.22
Debt to Equity
0.27
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2026
₹89.82Cr
+56.28%
₹9.67Cr
+42.31%
0255075100
2024
2025
2026

About

Accretion Pharmaceuticals Limited is engaged in the trading and marketing of pharmaceutical formulations and healthcare products.;
CEO/MD
Vivek Ashok Kumar Patel
Founded in
2023
NSE symbol
ACCPL
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,382.50
-38.90 (1.61%)
L
    H
    18,414.2127.165.46
    PfizerPFIZER
    ₹3,856.00
    -0.90 (0.02%)
    L
      H
      17,641.2420.534.2
      ₹6,373.50
      +79.50 (1.26%)
      L
        H
        15,737.2592.7818.03
        Natco PharmaNATCOPHARM
        ₹807.00
        +10.40 (1.31%)
        L
          H
          15,623.8013.651.49
          Recent news is not available for this stock
          2026
          31
          Oct
          Quarterly Result
          Release date
          8
          May
          Annual Result
          Release date
          2025
          14
          Nov
          Result
          Release date
          Events calendar
          View upcoming events in other stocks